Skip to main content
. 2021 Jun 21;11(6):584. doi: 10.3390/jpm11060584

Table 1.

Summary of published experience of RTaTME performed with da Vinci® Robotic platform.

Atallah
(2013)
Atallah
(2014)
Verheijen
(2014)
Huscher
(2015)
Gomez-Ruiz
(2015)
Kuo
(2016)
Monsellato
(2019)
Hu
(2020)
Ye
(2020)
Number of patients 1 3 1 7 5 15 3 20 13
Abdominal approach Laparoscopic Laparoscopic Laparoscopic Laparoscopic Robotic Single port robotic + assistant port Robotic 2, laparoscopic 1 Laparoscopic Robotic 9,
Laparoscopic 4
Transanal
platform
GelPoint Path
(daVinci® Si)
GelPoint Path
(daVinci® Si)
GelPoint Path
(daVinci® Si)
GelPoint Path
(daVinci® Si)
PAT * + GelPoint Path
(daVinci® Si)
GelPoint Path
(daVinci® Si)
GelPoint Path
(daVinci® Si)
GelPoint Path
(daVinci® Xi)
GelPoint Path
(daVinci® Si)
Two-team
approach
No No No No No No 1/3 20/20 4/13
BL (mL) 140 200 50 n/a 90
(25–120)
33
(30–50)
n/a 82
(30–500)
60
(50–100)
LOS (days) No 4.3 3 6 (5–7) 12.2 (10–14) 10 (7–15) 8.8 (6–24) 7 (6–10)
Conversion No No No No No 2/15 No No No
Hand-sewn anastomosis 0/1 2/3 0/1 0/7 2/5 15/15 3/3 2/20 8/13
Defunctioning stoma Terminal ileostomy Yes Yes Yes Yes 5/15 Yes 14/18 Yes
Operative
time (min)
381 376 205 165.7 (85–220) 398
(270–450)
473
(335–569)
550
(440–600)
172.3
(135–215)
240
(195–270)
Complications No 1 Pulmonary embolism
1 Peristomal dermatitis/
dehydration
No 1 anastomotic
bleeding
1 anastomotic
leak
1 mechanical
bowel
obstruction, 1
wound infection
1 acute renal failure 7/20
(no anastomotic
leaks reported)
1 post-op ileus
1 duodenal hemorrage
1 anastomotic leakage
TME quality
C/NC/I
0/1/0 1/2/0 1/0/0 6/1/0 5/0/0 15/0/0 3/0/0 18/2/0 8/5/0
CRM involvement No No No No No No No 3/20 No
Distal margin involvement No No No No No No No No No

BL: Blood loss; LOS: Length of hospital stay, C: Complete; NC: Near complete; I: Incomplete; * PAT (‘Puerto Acceso Transanal’—Developia-HUMV, Santander, Spain).